Raffaele Baffa - 17 May 2021 Form 4 Insider Report for ZIOPHARM ONCOLOGY INC (TCRT)

Role
Chief Medical Officer
Signature
/s/ Robert Hadfield, Attorney-in-Fact
Issuer symbol
TCRT
Transactions as of
17 May 2021
Net transactions value
$0
Form type
4
Filing time
19 May 2021, 16:55:10 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Award $0 +80,645 +40% $0.000000 280,645 17 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares vest on each of September 1, 2021, February 1, 2022 and May 1, 2022, subject to the Reporting Person's continued service through each such date.